These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31807952)

  • 1. The catecholaldehyde hypothesis: where MAO fits in.
    Goldstein DS
    J Neural Transm (Vienna); 2020 Feb; 127(2):169-177. PubMed ID: 31807952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.
    Goldstein DS
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
    J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.
    Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
    J Pharmacol Exp Ther; 2016 Feb; 356(2):483-92. PubMed ID: 26574516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Sullivan R; Gross DJ; Holmes C; Kopin IJ; Sharabi Y
    J Neurochem; 2012 Dec; 123(6):932-43. PubMed ID: 22906103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
    Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y
    J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
    Goldstein DS
    Semin Neurol; 2020 Oct; 40(5):502-514. PubMed ID: 32906170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
    Jinsmaa Y; Isonaka R; Sharabi Y; Goldstein DS
    J Pharmacol Exp Ther; 2020 Feb; 372(2):157-165. PubMed ID: 31744850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.
    Jinsmaa Y; Cooney A; Sullivan P; Sharabi Y; Goldstein DS
    Neurosci Lett; 2015 Mar; 590():134-7. PubMed ID: 25637699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.
    Jinsmaa Y; Florang VR; Rees JN; Anderson DG; Strack S; Doorn JA
    Chem Res Toxicol; 2009 May; 22(5):835-41. PubMed ID: 19388687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
    Goldstein DS; Sullivan P; Holmes C; Kopin IJ; Sharabi Y; Mash DC
    Parkinsonism Relat Disord; 2015 Jun; 21(6):567-72. PubMed ID: 25829070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
    Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
    Neurochem Res; 2016 Sep; 41(9):2173-8. PubMed ID: 27220335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate.
    Rees JN; Florang VR; Anderson DG; Doorn JA
    Chem Res Toxicol; 2007 Oct; 20(10):1536-42. PubMed ID: 17887726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.
    Goldstein DS; Kopin IJ; Sharabi Y
    Pharmacol Ther; 2014 Dec; 144(3):268-82. PubMed ID: 24945828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones.
    Legros H; Janin F; Dourmap N; Bonnet JJ; Costentin J
    J Neurosci Res; 2004 Feb; 75(3):429-35. PubMed ID: 14743456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.
    Burke WJ; Kumar VB; Pandey N; Panneton WM; Gan Q; Franko MW; O'Dell M; Li SW; Pan Y; Chung HD; Galvin JE
    Acta Neuropathol; 2008 Feb; 115(2):193-203. PubMed ID: 17965867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heart of PD: Lewy body diseases as neurocardiologic disorders.
    Goldstein DS; Sharabi Y
    Brain Res; 2019 Jan; 1702():74-84. PubMed ID: 29030055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
    Jinsmaa Y; Sullivan P; Gross D; Cooney A; Sharabi Y; Goldstein DS
    Neurosci Lett; 2014 May; 569():27-32. PubMed ID: 24670480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
    Florang VR; Rees JN; Brogden NK; Anderson DG; Hurley TD; Doorn JA
    Neurotoxicology; 2007 Jan; 28(1):76-82. PubMed ID: 16956664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).
    Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D
    J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.